Circulating Tumor Cells (CTCs), Melatonin, and uNOS: New Frontiers in Cancer Diagnosis and Treatment
Saved in:
| Main Authors: | A. Tavartkiladze, P. Revazishvili, T. Potskhoraia, L. Tavartkiladze |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-11-01
|
| Series: | The Journal of Liquid Biopsy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950195423000577 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heterogeneity of Somatostatin Receptors on Circulating Tumor Cells in Neuroendocrine Tumors and Melatonin's Potential in Non-Small-Cell Lung Cancer
by: A. Tavartkiladze, et al.
Published: (2023-11-01) -
Clinical significance of genomic sequencing of circulating tumour cells (CTCs) in cancer
by: Abdul Auwal, et al.
Published: (2024-03-01) -
TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs
by: Qingyu Liao, et al.
Published: (2024-03-01) -
Liquid Biopsy Characterization of CTCs and THCs Isolated in Patients with UC
by: C. Rubio, et al.
Published: (2023-11-01) -
Editorial: Unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine
by: Chiara Nicolazzo, et al.
Published: (2024-11-01)